NBL is a complex and heterogeneous disease with several factors determining the clinical outcome, especially the age at diagnosis, stage of the disease (localized vs. metastasizing), and biological features of the tumor (MYCN copy number determined by fluorescence in situ hybridization, DNA content measured by flow cytometry, and tumor histology evaluated using the International NBL Pathology Classification system). Here, MYCN is linked to neoplasm.